scispace - formally typeset
Journal ArticleDOI

Idiopathic congenital central hypoventilation syndrome: Diagnosis and management

TLDR
Infants with CCHS need to be evaluated in pediatric referral centers that have expertise in this category of abnormality both from the diagnostic and treatment perspectives, and have the interest and expertise to provide and/or coordinate the long-term followup.
Abstract
1. To improve general knowledge regarding idiopathic congenital central hypoventilation syndrome (CCHS), with recognition that because of the rarity of CCHS, many practitioners have not seen a case and therefore do not make the diagnosis in a timely manner. 2. To minimize time delays between onset of clinical symptoms and the diagnosis of CCHS, thereby decreasing initial health care costs and minimizing exposure to significant asphyxia and the development of car pulmonale. 3. To familiarize practitioners with available diagnostic and treatment options, home health care options, and longterm outcomes. Because there may not be an intrinsic risk of neurodevelopmental sequelae due to CCHS, normal neurologic outcome should be achievable assuming that a timely diagnosis can be made and the infant managed appropriately so as to avoid acute and chronic asphyxia. Because mortality in CCHS appears to be primarily related to acute or chronic asphyxia, optimal long-term ventilatory and tracheostomy care (acute asphyxia) and prevention of car pulmonale (due to chronic asphyxia) can minimize this risk. 4. To identify available referral options for state-of-the-art diagnosis and treatment, including resources for long-term evaluations. Access to a sleep laboratory that evaluates children is not sufficient. Infants with CCHS need to be evaluated in pediatric referral centers that have expertise in this category of abnormality both from the diagnostic and treatment perspectives, and have the interest and expertise to provide and/or coordinate the long-term followup. 5. To recognize the important concepts about respiratory control and state-related cardiorespiratory and autonomic function that can be learned from the care of children with CCHS.

read more

Citations
More filters
Journal ArticleDOI

Central Sleep Apnea: Pathophysiology and Treatment

TL;DR: The underlying physiology and modulating components influencing ventilatory control in CSA are summarized, the etiology of each of the various forms of CSA is described, and the key factors that may exacerbate apnea severity are examined.
Journal ArticleDOI

An Official ATS Clinical Policy Statement: Congenital Central Hypoventilation Syndrome: Genetic Basis, Diagnosis, and Management

TL;DR: The importance of PHOX2B testing in diagnosing and treating patients with CCHS is demonstrated and a review of pertinent literature allowed for the development of a document that summarizes recent advances in understanding CCHs and expert interpretation of the evidence for management of affected patients.
Journal ArticleDOI

Classification of Sleep Disorders

TL;DR: The International Classification of Sleep Disorders, version 2, published in 2005 and currently undergoing revision, combines a symptomatic presentation with 1 organized in part on pathophysiology and in parton body systems to more easily differentiate between the disorders.
Journal ArticleDOI

Idiopathic congenital central hypoventilation syndrome: Analysis of genes pertinent to early autonomic nervous system embryologic development and identification of mutations in PHOX2b

TL;DR: Genes pertinent to early embryologic development of the ANS including mammalian achaete‐scute homolog‐1 (MASH1), bone morphogenic protein‐2 (BMP2), engrailed‐1(EN1), TLX3, endothelin converting enzyme‐ 1 (ECE1), endothelins‐1 ('EDN1), PHOX2a, andPHOX2b are studied in 67 probands with CCHS, and gender‐
Journal ArticleDOI

PHOX2B mutations and polyalanine expansions correlate with the severity of the respiratory phenotype and associated symptoms in both congenital and late onset Central Hypoventilation syndrome

TL;DR: A family transmission study has shown that the risk of developing an ANSD symptom including CCHS, regarded as the most severe expression of ANS imbalance, mainly depends on the genotype at a major locus, while significant residual variants could be due to additional minor genes, modifying loci effects or environmental factors.
References
More filters
Journal ArticleDOI

A missense mutation of the endothelin-B receptor gene in multigenic hirschsprung's disease

TL;DR: This work has identified in HSCR patients a G-->T missense mutation in EDNRB exon 4 that substitutes the highly conserved Trp-276 residue in the fifth transmembrane helix of the G protein-coupled receptor with a Cys residue (W276C).
Journal ArticleDOI

GDNF signalling through the Ret receptor tyrosine kinase

TL;DR: It is shown that glial-cell-line-derived neurotrophic factor (GDNF)7, a distant member of the transforming growth factor(TGF)-β superfamily, signals through the Ret RTK, and that GDNF, in addition to its potential role in the differentiation and survival of central nervous system neurons8–12, has profound effects on kidney organogenesis and the development of the peripheral nervous system.
Journal ArticleDOI

The neurocristopathies: A unifying concept of disease arising in neural crest maldevelopment

Robert P. Bolande
- 01 Jul 1974 - 
TL;DR: Pheochromocytomas, neuroblastoma, neurofibromatosis, medullary carcinoma of the thyroid, carcinoid tumors, Hirschsprung's disease, and nonchromaffin paragangliomas are discussed and analysed in terms of their proposed neural crest origins.
Journal ArticleDOI

Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome)

TL;DR: A homozygous substitution/deletion mutation of the EDA/3 gene is reported in a WS-HSCR patient, supporting the view that the endothelin-signaling pathways play a major role in the development of neural crests.
Related Papers (5)